Search
for
Sort by
Research 421–450 of 1000+
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- Evaluation and treatment of male and female pattern hair loss
- Topical minoxidil in early male pattern baldness
- Dermatologic manifestations of endocrine disorders
- Hair growth promoting effects of adipose tissue-derived stem cells
- HAIR DIAMETER IN FEMALE BALDNESS
- Wnt signaling: the good and the bad
- Congenital hypotrichosis due to short anagen
- Loose anagen hair syndrome
- Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia
- Studying the genetic predisposing factors in the pathogenesis of acne vulgaris
- Lymphoid Enhancer-binding Factor-1 (LEF1) Interacts with the DNA-binding Domain of the Vitamin D Receptor
- Trichoscopy in Hair Shaft Disorders
- Marie Antoinette Syndrome
- Circulatory Changes in Alopecia
- Androgenetic alopecia and insulin resistance: are they truly associated?
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- Shedding: How to manage a common cause of hair loss
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Correction of the High Female Hairline
- The Potential Role of Minoxidil in the Hair Transplantation Setting
- Diagnostic approach to low‐renin hypertension
- Deficient Plakophilin-1 Expression Due to a Mutation in PKP1 Causes Ectodermal Dysplasia-Skin Fragility Syndrome in Chesapeake Bay Retriever Dogs
- Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment
- LncRNA PlncRNA‑1 regulates proliferation and differentiation of hair follicle stem cells through TGF‑β1‑mediated Wnt/β‑catenin signal pathway
- <i>Pten</i> loss in Lgr5<sup>+</sup> hair follicle stem cells promotes SCC development
- PTCH1 Germline Mutations and the Basaloid Follicular Hamartoma Values in the Tumor Spectrum of Basal Cell Carcinoma Syndrome (NBCCS)
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- Hair and Nail Relationship
- Secondary cicatricial and other permanent alopecias